Search

Displaying results 9671 - 9679 of 9679 in total
  1. Drug

    Copper histidinate

    go.drugbank.com/drugs/DB32041
    Approved

    Menkes disease is a rare, X-linked recessive disorder caused by pathogenic variants in the ATP7A gene, which encodes a copper transport protein essential for absorbing dietary copper and transporting it … [A275383] Copper histidinate is a subcutaneously-administered copper-histidine complex that allows for copper supplementation in patients with defective ATP7A transporters.

  2. Drug

    IL21120033

    go.drugbank.com/drugs/DB32508
    Experimental

    IL21120033 is a first-in-class, small-molecule selective CXCR7 agonist.

  3. Drug

    ZKN-013

    go.drugbank.com/drugs/DB32582
    Experimental

    ZKN-013 is a readthrough inducer under investigation for rare dermatological diseases.[L56075]

  4. Drug

    SW033291

    go.drugbank.com/drugs/DB32765
    Experimental

    SW033291 is a small molecule 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor.

  5. Drug

    GLB-008

    go.drugbank.com/drugs/DB32800
    Experimental

    GLB-008 is a molecular glue degrader targeting VAV1.[L56125, L56126]

  6. Drug

    XM146-MPA-SN38

    go.drugbank.com/drugs/DB32865
    Experimental

    XM146-MPA-SN38 is a PDL1-targeting polypeptide-MPA-SN38 conjugate.

  7. Drug

    TN-301

    go.drugbank.com/drugs/DB32867
    Experimental

    TN-301 is a small-molecule histone deacetylase 6 inhibitor.

  8. Drug

    AZD-8965

    go.drugbank.com/drugs/DB32868
    Experimental

    AZD-8965 is a small molecule inhibitor of ARG-1 and ARG-2.

  9. Drug

    RGN6024

    go.drugbank.com/drugs/DB33059
    Experimental

    RGN6024, also known as RGN-6024 or RGNi6024, is a synthetic small-molecule tubulin destabilizer from Reglagene.